← Back to Search
Clinical Dose-volume Histogram Analysis For Pneumonitis After 3D Treatment For Non-small Cell Lung Cancer (NSCLC)
M. Graham, J. Purdy, B. Emami, W. Harms, W. Bosch, M. Lockett, C. Perez
Published 1999 · Medicine
Download PDFAnalyze on Scholarcy
PURPOSE To identify a clinically relevant and available parameter upon which to identify non-small cell lung cancer (NSCLC) patients at risk for pneumonitis when treated with three-dimensional (3D) radiation therapy. METHODS AND MATERIALS Between January 1991 and October 1995, 99 patients were treated definitively for inoperable NSCLC. Patients were selected for good performance status (96%) and absence of weight loss (82%). All patients had full 3D treatment planning (including total lung dose-volume histograms [DVHs]) prior to treatment delivery. The total lung DVH parameters were compared with the incidence and grade of pneumonitis after treatment. RESULTS Univariate analysis revealed the percent of the total lung volume exceeding 20 Gy (V20), the effective volume (Veff) and the total lung volume mean dose, and location of the tumor primary (upper versus lower lobes) to be statistically significant relative to the development of > or = Grade 2 pneumonitis. Multivariate analysis revealed the V20 to be the single independent predictor of pneumonitis. CONCLUSIONS The V20 from the total lung DVH is a useful parameter easily obtained from most 3D treatment planning systems. The V20 may be useful in comparing competing treatment plans to evaluate the risk of pneumonitis for our individual patient treatment and may also be a useful parameter upon which to stratify patients or prospective dose escalation trials.
This paper references
Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.
G. Kutcher (1989)
Innovations in Three-Dimensional Treatment Planning and Quality Assurance
J. Michalski (1998)
Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.
D. Oetzel (1995)
Fitting of normal tissue tolerance data to an analytic function.
C. Burman (1991)
The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)-analysis of a radiation therapy oncology group (RTOG) protocol
R. Byhardt (1993)
Evaluation of an objective plan-evaluation model in the three dimensional treatment of nonsmall cell lung cancer.
M. Graham (1996)
IMEX: A Tool For Image Display And Contour Management In A Windowing Environment
P. Mills (1989)
Dose rate relationships in brachytherapy: An in-vivo evaluation
S. O. Stephens (1977)
Tolerance of normal tissue to therapeutic irradiation.
B. Emami (1991)
The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy.
M. Anscher (1998)
Advances in three-dimensional treatment planning and conformal dose delivery.
Purdy Ja (1997)
BMDP statistical software
W. Dixon (1983)
Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis.
M. Martel (1994)
Three-dimensional treatment planning and conformal dose delivery--a physicist's perspective.
J. Purdy (1998)
The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol.
R. Byhardt (1993)
Advances in 3-dimensional radiation treatment planning systems: room-view display with real time interactivity.
J. Purdy (1993)
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.
S. L. Kwa (1998)
Physical and biological predictors of changes in whole-lung function following thoracic irradiation.
L. Marks (1997)
Computer-controlled delivery of 3D conformal radiation treatments.
R. Mohan (1998)
Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis.
M. Anscher (1997)
Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis.
M. Anscher (1998)
Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation.
F. Geara (1998)
Predicting radiation response.
M. Graham (1997)
This paper is referenced by
Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease
D. Antoni (2013)
Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities
Hisao Higo (2019)
Influence of respiration on dose calculation in stereotactic body radiotherapy of the lung
Rie Yamazaki (2014)
The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers.
S. Mukherjee (2003)
Assessing the Need for Adjusted Organ-at-Risk Planning Goals for Patients Undergoing Adjuvant Radiation Therapy for Locally Advanced Breast Cancer with Proton Radiation.
C. Decesaris (2020)
Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.
R. Castillo (2015)
Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study.
D. Ruysscher (2005)
Tomographie par émission de positons et détection en coïncidence (TEDC) et recalage d'images de simulation virtuelle par tomodensitométrie. Impact sur la planification de la radiothérapie conformationnelle des cancers bronchiques non à petites cellules
E. Deniaud-Alexandre (2005)
Chapte rr 4 FIELDD SIZE REDUCTION ENABLES ISO-NTCP ESCALATIONN OF TUMOR CONTROL PROBABILIT Y FORR IRRADIATION OF LUNG TUMORS
M. Engelsman (2007)
Dosimetric comparison between helical tomotherapy and intensity‐modulated radiotherapy for esophageal carcinoma
Q. Gu (2017)
Image-guided intensity-modulated radiotherapy for refractory bilateral breast cancer in a patient with extensive cutaneous metastasis in the chest and abdominal walls
Yueh-Feng Lu (2016)
Should breathing adapted radiotherapy also be applied for right-sided breast irradiation?
M. Essers (2016)
Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer
B. Terakedis (2011)
Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer
T. Inoue (2013)
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
D. Rice (2007)
Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
Sonal Sura (2008)
On the use of published radiobiological parameters and the evaluation of NTCP models regarding lung pneumonitis in clinical breast radiotherapy
Patricia Svolos (2010)
Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.
A. Nanda (2008)
Conformal radiotherapy for Non-Small Cell Lung Cancer (NSCLC) to the dose of 70-74 Gy with or without elective nodal irradiation (ENI). Results and patterns of failures
L. Kępka (2004)
Stereotaktische Bestrahlung von Lungentumoren
H. Hof (2004)
CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancer.
J. Lester (2004)
Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.
J. Fenwick (2009)
Curative radiotherapy for a second primary lung cancer arising after pneumonectomy -- techniques and results.
F. Lagerwaard (2002)
The Role of IMRT in Lung Cancer : Guideline Recommendations
A. Bezjak (2015)
A Retrospective Analysis of Dose Distribution and Toxicity in Patients with Left Breast Cancer Treated with Adjuvant Intensity-Modulated Radiotherapy: Comparison with Three-Dimensional Conformal Radiotherapy
Chia-Hsin Chen (2020)
Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields
A. Stewart (2008)
A Quantitative LQ-based Model for Lung Injury in Radiotherapy
L. Wang (2015)
4D dose-position verification in radiation therapy using the RADPOS system in a deformable lung phantom.
A. Cherpak (2011)
Mechanistic modelling of radiotherapy-induced lung toxicity.
E. Rutkowska (2012)
Dosimetric comparison and biological evaluation of PET- and CT-based target delineation for LA-NSCLC using auto-planning.
Yan Shao (2019)
Self‐expanding stent effects on radiation dosimetry in esophageal cancer
Samual R. Francis (2013)
Optimal beam arrangement for pulmonary ventilation image-guided intensity-modulated radiotherapy for lung cancer
R. Wang (2014)See more